Understanding Data from the TRANSCEND Trial | CAR T-Cell Therapy for CLL
Experts responded to viewer questions about CAR T-cell therapy during the Feb 7, 2024 virtual town hall.
How Is CLL Treatment Guided by Cytogenetic Testing?
Experts responded to viewer questions about CLL and cytogenetic testing during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Can Chronic Lymphocytic Leukemia (CLL) Be Inherited?
Experts responded to a viewer question about familial CLL during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
What’s Vital to Understand About MRD Status in CLL?
Experts responded to a viewer question about minimal residual disease during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
CLL Global Research Foundation | Research Updates
Dr. William Wierda discussed the latest research funded by the CLL Global Research Foundation during the Feb 7, 2024 virtual town hall.
How Do You Know When CLL Treatment Should Begin?
Experts responded to a viewer question about the CLL watch & wait period during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Understanding What the CLL 10-Year Progression-Free Survival of Ibrutinib Means
Experts explained the meaning of the CLL 10-year progression-free survival of Ibrutinib during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Are CLL Patients At-Risk for AML or CML?
Experts responded to a viewer question about the risk of AML and CML during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
What’s the Outlook for Future CLL Care?
Dr. William Wierda and Dr. Patrick Reville share their hope for the future of CLL care.
CLL Research Updates From ASH 2023
Experts discussed the latest updates from the 2023 American Society of Hematology (ASH) meeting.